openPR Logo
Press release

Lawsuit filed in effort to recover losses for investors who lost money with shares of Innodata Inc. (NASDAQ: INOD)

02-29-2024 08:23 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A lawsuit was filed on behalf of investors in Innodata Inc. (NASDAQ: INOD) shares over alleged securities laws violations.

A lawsuit was filed on behalf of investors in Innodata Inc. (NASDAQ: INOD) shares over alleged securities laws violations.

An investor, who purchased shares of Innodata Inc. (NASDAQ: INOD), filed a lawsuit against Innodata Inc. over alleged violations of Federal Securities Laws.

Investors who purchased shares of Innodata Inc. (NASDAQ: INOD) have certain options and for certain investors are short and strict deadlines running. Deadline: April 22, 2024. NASDAQ: INOD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Ridgefield Park, NJ based Innodata Inc. operates as a global data engineering company in the United States, the United Kingdom, the Netherlands, Canada, and internationally.

On February 15, 2024, Wolfpack Research published a report alleging, among other things, that Innodata is "a deteriorating, manual data-entry business driven by offshore labor, not innovation." Wolfpack further alleged that "[s]igns that [Innodata] is not an AI company are everywhere" noting the Company's minimal spending on cloud services and R&D, as well as the fact that "96% of [its] workforce is overseas and its average employee generates less than $20k of revenue annually

Shares of Innodata Inc. (NASDAQ: INOD) declined from $12.17 per share on February 12, 2024 to low as $6.78 per share on February 26, 2024.

The plaintiff claims that between May 9, 2019 and February 14, 2024, the Defendants made false and/or misleading statements, as well as failed to disclose material facts, including that Innodata: did not have a viable AI technology, that its Goldengate AI platform is a rudimentary software developed by just a handful of employees, that it was not going to utilize AI to any significant degree for new Silicon Valley contracts, that it was not effectively investing in research and development for AI, and that based on the foregoing, Defendants lacked a reasonable basis for their positive statements about Innodata's AI business and development and related financial results, growth, and prospects.

Those who purchased shares of Innodata Inc. (NASDAQ: INOD) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed in effort to recover losses for investors who lost money with shares of Innodata Inc. (NASDAQ: INOD) here

News-ID: 3404920 • Views:

More Releases from Shareholders Foundation

Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, 2025
Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd. Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
Investigation announced for Long-Term Investors in shares of West Pharmaceutical Services, Inc. (NYSE: WST) over potential Wrongdoing
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc.. Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed
Investigation announced for Long-Term Investors in Open Lending Corporation (NASDAQ: LPRO) over potential Wrongdoing
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation. Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings, Inc. (NYSE: BBAI)
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced. Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm

All 5 Releases


More Releases for Innodata

Investigation announced for Long-Term Investors in shares of Innodata Inc. (NASD …
An investigation was announced for investors in shares of Innodata Inc. (NASDAQ: INOD) concerning potential breaches of fiduciary duties by certain directors and officers of Innodata Inc. Investors who are current long term investors in Innodata Inc. (NASDAQ: INOD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: INOD stocks
PR Analytic Software Market 2023: Some Basic Influencing Factors Making It's Boo …
The PR Analytic Software market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The PR Analytic Software report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. The PR Analytic Software research report also provides insights of different
Global Healthcare Data Annotation Tools Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Healthcare Data Annotation Tools Market is expected to grow at a CAGR of 27.5% from 2023 to 2028. Healthcare data annotation tools play a critical role in ensuring accurate and reliable data labeling, which is essential for training effective machine learning models. as a result, the growing adoption of machine learning in the healthcare sector is expected
Data Annotation Market to Witness Huge Growth by Key Players: iMerit, Scale AI, …
According to Market Study Report, Data Annotation Market provides a comprehensive analysis of the Data Annotation Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=6142789 The report provides a comprehensive analysis of company profiles listed below: -Amazon Mechanical Turk, Inc. -iMerit -Scale AI -Appen Limited -Cogito -Clickworker GmbH -Lionbridge -Deepen
PR Analytics Software Market 2022 to 2028- Industry Regional Developments, Compe …
The PR Analytics Software market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with
Global Data Annotation Tools Market Value & Forecasts Upto 2026
The Global data annotation market was valued at US$ 320.0 Million in 2018 and is expected to reach US$ 1,820 Million by the year 2026, growing at a CAGR of ~24.5% during the forecast period. Increasing investments in research & development for autonomous vehicles are also contributes significantly to the growth of the market. Data annotation tools are playing an important role in the enhancement of AI applications in medical